Filing Flows › AIM ImmunoTech (AIM) › Stock forecast & fair value
AIM ImmunoTech (AIM) stock forecast and price target
AIM ImmunoTech (AIM) trades at $0.15. 2 analysts' median price target is $4.25 (27×), from $1.50 to $7.00.
AIM ImmunoTech's latest quarter
AIM ImmunoTech, Q2 2026: revenue $26K (+4% year over year), net loss $3.8M, operating cash flow −$4.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for AIM stock?
The median of 2 analysts' 12-month targets is $4.25, 27× from $0.15; the range is $1.50 to $7.00. The average rating is none.
Does AIM ImmunoTech usually beat earnings estimates?
It beat the consensus EPS estimate in 25% of the quarters on record.
Is AIM stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.